from 31 Dec 2010 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary: WINDTREE THERAPEUTICS INC /DE/ quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2010 to 31 Mar 2025.
WINDTREE THERAPEUTICS INC /DE/ Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $2,407,000, a 18% increase year-over-year.
WINDTREE THERAPEUTICS INC /DE/ annual Net Cash Provided by (Used in) Operating Activities for 2024 was $15,402,000, a 15% decline from 2023.
WINDTREE THERAPEUTICS INC /DE/ annual Net Cash Provided by (Used in) Operating Activities for 2023 was $13,437,000, a 31% increase from 2022.
WINDTREE THERAPEUTICS INC /DE/ annual Net Cash Provided by (Used in) Operating Activities for 2022 was $19,452,000, a 18% increase from 2021.
Source SEC data: View on sec.gov

Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)

Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)

Net Cash Provided by (Used in) Operating Activities, Annual (USD)

Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$2,407,000	+$540,000	+18%	01 Jan 2025	31 Mar 2025	10-Q	15 May 2025	2025	Q1
Q1 2024	$2,947,000	-$428,000	-17%	01 Jan 2024	31 Mar 2024	10-Q	15 May 2025	2025	Q1
Q1 2023	$2,519,000	+$4,196,000	+62%	01 Jan 2023	31 Mar 2023	10-Q	15 May 2024	2024	Q1
Q1 2022	$6,715,000	-$667,000	-11%	01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1
Q1 2021	$6,048,000	-$566,000	-10%	01 Jan 2021	31 Mar 2021	10-Q	05 May 2022	2022	Q1
Q1 2020	$5,482,000	+$3,277,000	+37%	01 Jan 2020	31 Mar 2020	10-Q	13 May 2021	2021	Q1
Q1 2019	$8,759,000	-$6,213,000	-244%	01 Jan 2019	31 Mar 2019	10-Q	13 May 2020	2020	Q1
Q1 2018	$2,546,000	+$4,786,000	+65%	01 Jan 2018	31 Mar 2018	10-Q	20 May 2019	2019	Q1
Q1 2017	$7,332,000			01 Jan 2017	31 Mar 2017	10-Q	21 May 2018	2018	Q1
Q1 2014	$10,279,000	-$44,000	-0.43%	01 Jan 2014	31 Mar 2014	10-Q	12 May 2014	2014	Q1
Q1 2013	$10,235,000	-$4,689,000	-85%	01 Jan 2013	31 Mar 2013	10-Q	12 May 2014	2014	Q1
Q1 2012	$5,546,000	-$477,000	-9.4%	01 Jan 2012	31 Mar 2012	10-Q	07 May 2013	2013	Q1
Q1 2011	$5,069,000			01 Jan 2011	31 Mar 2011	10-Q	15 May 2012	2012	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$15,402,000	-$1,965,000	-15%	01 Jan 2024	31 Dec 2024	10-K	15 Apr 2025	2024	FY
2023	$13,437,000	+$6,015,000	+31%	01 Jan 2023	31 Dec 2023	10-K	15 Apr 2025	2024	FY
2022	$19,452,000	+$4,212,000	+18%	01 Jan 2022	31 Dec 2022	10-K	16 Apr 2024	2023	FY
2021	$23,664,000	+$1,651,000	+6.5%	01 Jan 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY
2020	$25,315,000	-$652,000	-2.6%	01 Jan 2020	31 Dec 2020	10-K	31 Mar 2022	2021	FY
2019	$24,663,000	-$8,882,000	-56%	01 Jan 2019	31 Dec 2019	10-K	29 Mar 2021	2020	FY
2018	$15,781,000	+$5,264,000	+25%	01 Jan 2018	31 Dec 2018	10-K	03 Apr 2020	2019	FY
2017	$21,045,000	+$12,544,000	+37%	01 Jan 2017	31 Dec 2017	10-K/A	23 Apr 2019	2018	FY
2016	$33,589,000			01 Jan 2016	31 Dec 2016	10-K	17 Apr 2018	2017	FY
2013	$40,454,000	-$7,570,000	-23%	01 Jan 2013	31 Dec 2013	10-K	17 Mar 2014	2013	FY
2012	$32,884,000	-$10,186,000	-45%	01 Jan 2012	31 Dec 2012	10-K	17 Mar 2014	2013	FY
2011	$22,698,000	+$1,572,000	+6.5%	01 Jan 2011	31 Dec 2011	10-K	17 Mar 2014	2013	FY
2010	$24,270,000			01 Jan 2010	31 Dec 2010	10-K	15 Mar 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.